Captopril (SQ 14,225) (D-3-mercapto-2-methylpropranoyl-L-proline): a novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent.
D000208:Acute Disease; D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D002908:Chronic Disease; D004285:Dogs; D006168:Guinea Pigs; D000882:Haplorhini; D006973:Hypertension / Q000201:enzymology* / Q000235:genetics; D006977:Hypertension, Renal / Q000188:drug therapy; D007082:Ileum / Q000187:drug effects; D008253:Macaca mulatta; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D011392:Proline / Q000031:analogs & derivatives* / Q000494:pharmacology; D051381:Rats; D013722:Teprotide / Q000494:pharmacology
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D011392:Proline; D013722:Teprotide